Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy
International Journal of Molecular Sciences · 14.07.2024 · 25 (14) · 7715
DOI: 10.3390/ijms25147715 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2024. Verfasst von Wenzhe Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology a…. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Drug Delivery Systems. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Guangdong Basic and Applied Basic Research Foundation, the Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Exosomes are small vesicles containing proteins, nucleic acids, and biological lipids, which are responsible for intercellular communication. Studies have shown that exosomes can be utilized as effective drug delivery vehicles to accurately deliver therapeutic substances to target tissues, enhancing therapeutic effects and reducing side effects. Mesenchymal stem cells (MSCs) are a class of stem cells widely used for tissue engineering, regenerative medicine, and immunotherapy. Exosomes derived from MSCs have special immunomodulatory functions, low immunogenicity, the ability to penetrate tumor tissues, and high yield, which are expected to be engineered into efficient drug delivery systems. Despite the promising promise of MSC-derived exosomes, exploring their optimal preparation methods, drug-loading modalities, and therapeutic potential remains challenging. Therefore, this article reviews the related characteristics, preparation methods, application, and potential risks of MSC-derived exosomes as drug delivery systems in order to find potential therapeutic breakthroughs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical Univer…
- Dongguan Sanhang Innovation Institute, Dongguan 523808, China.
ORCID-Profile: Ruichen Wang, Hui Yang, Leming Sun
Förderung
- National Natural Science Foundation of China
- the Guangdong Basic and Applied Basic Research Foundation
- the Fundamental Research Funds for the Central Universities
- the National Undergraduate Training Programs for Innovation and Entrepreneurship
Zitieren
APA
Zhao, W., Li, K., Li, L., Wang, R., Lei, Y., Yang, H., & Sun, L. (2024). Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy. International Journal of Molecular Sciences, 25(14), 7715. https://doi.org/10.3390/ijms25147715
Vancouver
Zhao W, Li K, Li L, Wang R, Lei Y, Yang H, et al. Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy. International Journal of Molecular Sciences. 2024;25(14):7715. doi:10.3390/ijms25147715
BibTeX
@article{Zhao2024,
author = {Zhao, Wenzhe and Li, Kaixuan and Li, Liangbo and Wang, Ruichen and Lei, Yang and Yang, Hui and Sun, Leming},
title = {Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {14},
pages = {7715},
doi = {10.3390/ijms25147715}
}
EUVIMED